Valuation: Implantica AG

Market Cap 1.89B 2.12B 1.76B 1.61B 3.03B 204B 3.06B 21.31B 8.26B 104B 7.97B 7.8B 335B P/E 2026 *
-22.3x
P/E 2027 * -18.1x
Enterprise Value 1.86B 2.09B 1.73B 1.58B 2.98B 201B 3.01B 20.99B 8.14B 103B 7.85B 7.68B 330B EV / Sales 2026 *
541x
EV / Sales 2027 * 206x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+1.90%
1 week+27.46%
Current month+1.08%
1 month+26.81%
3 months+19.18%
6 months+63.66%
Current year+50.10%
1 week 59.6
Extreme 59.6
78
1 month 56.4
Extreme 56.4
78
Current year 38
Extreme 38
80.3
1 year 38
Extreme 38
80.3
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
92
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 01/01/2015
Director of Finance/CFO 48 01/01/2020
Corporate Officer/Principal 69 -
Director TitleAgeSince
Chairman 67 01/01/2020
Director/Board Member 62 01/01/2020
Director/Board Member 71 01/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
3/31/26 A Buy

Chairman

28,135 0.0484%
9/24/25 A Sell

Chief Financial Officer

16,700 0.0287%
9/24/25 A Sell

Chief Financial Officer

17,100 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
+1.90%+27.46%+16.95%+251.40% 2.12B
+0.84%-3.74%-26.69%+1.85% 169B
-0.07%-2.55%-9.53%+11.07% 110B
+0.90%+1.13%-24.83%+0.58% 106B
-1.24%-0.76%-49.04%-12.75% 73.87B
-0.24%+0.69%+0.16%+72.58% 58.98B
-0.86%+2.96%+13.57%+59.50% 51.28B
-0.71%-3.82%-7.72%-31.41% 48.16B
+0.12%-0.17%-18.21%+20.29% 40.84B
-1.01%-1.45%+28.48%-9.72% 32.21B
Average -0.04%+1.97%-7.69%+36.34% 69.23B
Weighted average by Cap. +0.03%-1.21%-16.26%+10.87%

Financials

2026 *2027 *
Net sales 3.43M 3.86M 3.2M 2.92M 5.51M 372M 5.56M 38.78M 15.03M 190M 14.51M 14.2M 610M 9.14M 10.29M 8.54M 7.78M 14.67M 989M 14.81M 103M 40.03M 506M 38.64M 37.8M 1.62B
Net income -20.78M -23.38M -19.39M -17.67M -33.33M -2.25B -33.64M -235M -90.94M -1.15B -87.8M -85.89M -3.69B -25.61M -28.82M -23.9M -21.79M -41.09M -2.77B -41.47M -289M -112M -1.42B -108M -106M -4.55B
Net Debt -28.02M -31.54M -26.16M -23.84M -44.96M -3.03B -45.38M -317M -123M -1.55B -118M -116M -4.97B -1.71M -1.92M -1.59M -1.45M -2.74M -185M -2.76M -19.28M -7.47M -94.42M -7.21M -7.06M -303M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
02/10/26 SEK 75.20 +1.90% 434,972
01/10/26 SEK 73.80 -0.81% 187,439
30/09/26 SEK 74.40 +13.41% 191,179
29/09/26 SEK 65.60 +8.25% 177,888
28/09/26 SEK 60.60 +2.71% 44,746
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
6.658EUR
Average target price
8.141EUR
Spread / Average Target
+22.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock